{"id":48736,"date":"2022-09-23T13:01:49","date_gmt":"2022-09-23T11:01:49","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\/"},"modified":"2022-09-23T13:01:49","modified_gmt":"2022-09-23T11:01:49","slug":"the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\/","title":{"rendered":"The Worldwide Neurotrophic Keratitis Industry is Expected to Reach $439 Million by 2027 &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5650830\/global-neurotrophic-keratitis-market-2022-2027?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=vmvqfl&amp;utm_campaign=1753942+-+The+Worldwide+Neurotrophic+Keratitis+Industry+is+Expected+to+Reach+%24439+Million+by+2027&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Global Neurotrophic Keratitis Market (2022-2027) by Route of Administration, Distribution Channel, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20220923005241\/en\/1581181\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20220923005241\/en\/1581181\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe Global Neurotrophic Keratitis Market is estimated to be worth USD 191.1 million in 2022, and is expected to reach USD 439.05 million by 2027, growing at a CAGR of 18.1%.\n<\/p>\n<p>\n<strong>Market Dynamics<\/strong>\n<\/p>\n<p>\nMarket dynamics are forces that impact the prices and behaviors of the stakeholders. These forces create pricing signals which result from the changes in the supply and demand curves for a given product or service. Forces of Market Dynamics may be related to macro-economic and micro-economic factors.\n<\/p>\n<p>\nThere are dynamic market forces other than price, demand, and supply. Human emotions can also drive decisions, influence the market, and create price signals. As the market dynamics impact the supply and demand curves, decision-makers aim to determine the best way to use various financial tools to stem various strategies for speeding the growth and reducing the risks.\n<\/p>\n<p>\n<strong>The Competitive Quadrant<\/strong>\n<\/p>\n<p>\nThe report includes the Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.\n<\/p>\n<p>\n<strong>Ansoff Analysis<\/strong>\n<\/p>\n<ul>\n<li>\nThe report presents a detailed Ansoff matrix analysis for the Global Neurotrophic Keratitis Market. Ansoff Matrix, also known as Product\/Market Expansion Grid, is a strategic tool used to design strategies for the growth of the company. The matrix can be used to evaluate approaches in four strategies viz. Market Development, Market Penetration, Product Development and Diversification. The matrix is also used for risk analysis to understand the risk involved with each approach.\n<\/li>\n<li>\nThe Global Neurotrophic Keratitis Market is analyzed using the Ansoff Matrix to provide the best approaches a company can take to improve its market position.\n<\/li>\n<li>\nBased on the SWOT analysis conducted on the industry and industry players, suitable strategies have been devised for market growth.\n<\/li>\n<\/ul>\n<p>\n<strong>Why Buy This Report?<\/strong>\n<\/p>\n<ul>\n<li>\nThe report offers a comprehensive evaluation of the Global Neurotrophic Keratitis Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.\n<\/li>\n<li>\nThe report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel within the industry.\n<\/li>\n<li>\nThe report includes an in-depth market analysis using Porter&#8217;s 5 forces model and the Ansoff Matrix. In addition, the impact of COVID-19 on the market is also featured in the report.\n<\/li>\n<li>\nThe report also includes the regulatory scenario within the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules &amp; regulations imposed on this sector across various geographies.\n<\/li>\n<li>\nThe report also contains competitive analysis using &#8216;Positioning Quadrants&#8217;; a proprietary competitive positioning tool.\n<\/li>\n<\/ul>\n<p>\n<strong>Market Dynamics<\/strong>\n<\/p>\n<p>\n<em><strong>Drivers<\/strong><\/em>\n<\/p>\n<ul>\n<li>\nRising Visual Impairment Due to Fungal Keratitis\n<\/li>\n<li>\nIncreasing Number of Fungal Keratitis in Regions with Mild Temperature Climates\n<\/li>\n<li>\nNumber of Contact Lens Wearers Has Been Increased, and Do Not Follow Directions for Proper Care of Contact Lenses\n<\/li>\n<\/ul>\n<p>\n<em><strong>Restraints<\/strong><\/em>\n<\/p>\n<ul>\n<li>\nNon-Availability of Antifungal Recommendations with Specific Fungal Isolation\n<\/li>\n<\/ul>\n<p>\n<em><strong>Opportunities<\/strong><\/em>\n<\/p>\n<ul>\n<li>\nAggressive Topical Antifungal Therapy for the Treatment\n<\/li>\n<li>\nNew Product Developments in the Treatments of Fungal Keratitis\n<\/li>\n<\/ul>\n<p>\n<em><strong>Challenges<\/strong><\/em>\n<\/p>\n<ul>\n<li>\nRising Number of Failed Medical Surgeries in a Reappearance of Fungus\n<\/li>\n<\/ul>\n<p>\n<strong>Market Segmentation<\/strong>\n<\/p>\n<p>\nThe Global Neurotrophic Keratitis Market is segmented based on Route of Administration, Distribution Channel, and Geography.\n<\/p>\n<ul>\n<li>\nBy Route of Administration, the market is classified into Injection, Oral, Topical.\n<\/li>\n<li>\nBy Distribution Channel, the market is classified into Drug Stores and Hospitals.\n<\/li>\n<li>\nBy Geography, the market is classified into Americas, Europe, Middle-East &amp; Africa and Asia-Pacific.\n<\/li>\n<\/ul>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAlvogen\n<\/li>\n<li>\nAurolab\n<\/li>\n<li>\nBausch Health\n<\/li>\n<li>\nEyevance\n<\/li>\n<li>\nGilead Biosciences\n<\/li>\n<li>\nGlenmark\n<\/li>\n<li>\nLeadiant Biosciences\n<\/li>\n<li>\nMerck\n<\/li>\n<li>\nNovo Holdings\n<\/li>\n<li>\nPfizer\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5650830\/global-neurotrophic-keratitis-market-2022-2027?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=vmvqfl&amp;utm_campaign=1753942+-+The+Worldwide+Neurotrophic+Keratitis+Industry+is+Expected+to+Reach+%24439+Million+by+2027&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/2gwu4a<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;&#108;&#x74;&#x6f;:&#x70;&#x72;e&#115;&#x73;&#64;&#114;&#x65;s&#101;&#x61;r&#99;&#x68;a&#110;&#x64;&#x6d;&#97;&#x72;&#x6b;&#101;&#x74;&#x73;&#46;&#x63;&#x6f;m\" rel=\"nofollow noopener\" shape=\"rect\">&#112;&#x72;e&#x73;&#x73;&#64;&#x72;e&#115;&#x65;&#97;&#x72;c&#104;&#x61;n&#x64;m&#97;&#x72;k&#x65;&#x74;&#115;&#x2e;c&#111;&#x6d;<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Neurotrophic Keratitis Market (2022-2027) by Route of Administration, Distribution Channel, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Neurotrophic Keratitis Market is estimated to be worth USD 191.1 million in 2022, and is expected to reach USD 439.05 million by &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-48736","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.6 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>The Worldwide Neurotrophic Keratitis Industry is Expected to Reach $439 Million by 2027 - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"The Worldwide Neurotrophic Keratitis Industry is Expected to Reach $439 Million by 2027 - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Neurotrophic Keratitis Market (2022-2027) by Route of Administration, Distribution Channel, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Neurotrophic Keratitis Market is estimated to be worth USD 191.1 million in 2022, and is expected to reach USD 439.05 million by ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-23T11:01:49+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20220923005241\/en\/1581181\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"The Worldwide Neurotrophic Keratitis Industry is Expected to Reach $439 Million by 2027 &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-09-23T11:01:49+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\\\/\"},\"wordCount\":722,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220923005241\\\/en\\\/1581181\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\\\/\",\"name\":\"The Worldwide Neurotrophic Keratitis Industry is Expected to Reach $439 Million by 2027 - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220923005241\\\/en\\\/1581181\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-09-23T11:01:49+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220923005241\\\/en\\\/1581181\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20220923005241\\\/en\\\/1581181\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"The Worldwide Neurotrophic Keratitis Industry is Expected to Reach $439 Million by 2027 &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"The Worldwide Neurotrophic Keratitis Industry is Expected to Reach $439 Million by 2027 - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"The Worldwide Neurotrophic Keratitis Industry is Expected to Reach $439 Million by 2027 - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Global Neurotrophic Keratitis Market (2022-2027) by Route of Administration, Distribution Channel, and Geography, with Competitive Analysis, Impact of COVID-19, and Ansoff Analysis&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Global Neurotrophic Keratitis Market is estimated to be worth USD 191.1 million in 2022, and is expected to reach USD 439.05 million by ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-09-23T11:01:49+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20220923005241\/en\/1581181\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"The Worldwide Neurotrophic Keratitis Industry is Expected to Reach $439 Million by 2027 &#8211; ResearchAndMarkets.com","datePublished":"2022-09-23T11:01:49+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\/"},"wordCount":722,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220923005241\/en\/1581181\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\/","name":"The Worldwide Neurotrophic Keratitis Industry is Expected to Reach $439 Million by 2027 - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20220923005241\/en\/1581181\/21\/logo.jpg","datePublished":"2022-09-23T11:01:49+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20220923005241\/en\/1581181\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20220923005241\/en\/1581181\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/the-worldwide-neurotrophic-keratitis-industry-is-expected-to-reach-439-million-by-2027-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"The Worldwide Neurotrophic Keratitis Industry is Expected to Reach $439 Million by 2027 &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48736","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=48736"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/48736\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=48736"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=48736"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=48736"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}